Wellington Management Company
Investments by market, targeted sectors and preferred funding rounds
Investor Type -
Preferred rounds -
Location
Investments by industry
biotech - 60%
healthtech - 20%
fintech - 20%
Number of investments: 5
Wellington Management Company invested in Entrada Therapeutics during a round worth $116,000,000 - 3/31/2021
Wellington Management Company invested in Verve Therapeutics during a round worth $94,000,000 - 1/19/2021
Wellington Management Company invested in Current during a round worth $131,000,000 - 11/26/2020
Wellington Management Company invested in Gracell Biotechnologies during a round worth $100,000,000 - 10/29/2020
Wellington Management Company invested in Freeline during a round worth $120,000,000 - 7/5/2020